effects [qlco]
regimens [inpr]
Hormone replacement therapy [topp]
haemostatic [ortf]
Parameters [fndg]
Study, Prospective [resa]
randomized [resa]
Objective [inpr]
effects [qlco]
regimens [inpr]
Including [ftcn]
Oral [spco]
Transdermal [ftcn]
Formulation [resa]
Progestins [horm, phsu, strd]
haemostatic [ortf]
System [ftcn]
prospective [resa]
randomized [resa]
Methods [inpr]
Eight [qnco]
Women [popg]
randomized [resa]
Group [idcn]
Receive [qlco]
Continuous [idcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
MU/day [qnco]
Te [elii, hops]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg day [qnco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Mg+2 [elii, phsu]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/mg [qnco]
Oral [spco]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
mg% [qnco]
Acetate [orch, phsu]
Patients [podg]
Received [qlco]
Estrogen [horm, phsu, strd]
Remaining [qlco]
Women [popg]
Received [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progesterone [horm, phsu, strd]
Combination [qlco]
regimens [inpr]
Marker [clna]
haemostatic [ortf]
System [ftcn]
Fibrinogen [aapp, bacs, phsu]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Measured [qlco]
Initially [tmco]
months [tmco]
therapy [ftcn]
treatment [ftcn]
Group [idcn]
Well [qlco]
matched [resa]
baseline [bodm]
Characteristics [qlco]
Including [ftcn]
Age [orga]
Height [orga]
weight [orga]
Body Mass Index [diap]
Systolic [tmco]
Diastolic blood pressure [clna]
Study [mnob]
fibrinogen levels [lbpr]
baseline [bodm]
Values [qlco]
Group [idcn]
Decrease [qlco]
statistically significant [qnco]
Patients [podg]
treated [topp]
Oral [spco]
mg day [qnco]
cee [orch]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Levels [qlco]
Decreased [qnco]
Te [elii, hops]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg day [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/mg [qnco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Decreased [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg day [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg/mg [qnco]
effects [qlco]
regimens [inpr]
Compared [acty]
Percentage [qnco]
baseline [bodm]
treatment [ftcn]
Group [idcn]
